Home LiteratureArticle Details
PMID: 8026474 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.

The EMBO journal ·Vol. 13 ·No. 12 ·1994-06-15 ·Pages 2897-903

Hagemeier C, Caswell R, Hayhurst G, Sinclair J, Kouzarides T

Abstract

The 86 kDa immediate early IE2 protein of human cytomegalovirus (HCMV) can activate transcription of both viral and cellular genes and can repress transcription from its own promoter. Using two in vivo assays, we provide evidence of a functional interaction between IE2 and the retinoblastoma (RB) protein: IE2 alleviates RB-induced repression of a promoter bearing E2F binding sites and RB alleviates IE2-mediated repression of its own promoter. These functional effects are likely to be a result of a direct contact between IE2 and RB, which we can demonstrate both in vitro and in HCMV-infected cells. The interaction between IE2 and RB shows similar characteristics to the interaction between RB and E1A. First, binding to IE2 requires an intact RB pocket domain. Secondly, the binding is sensitive to the phosphorylation state of RB, because cyclin A-CDK-induced phosphorylation of RB diminishes IE2 binding. Thirdly, the IE2 domain required for RB binding is separate to the domains necessary for TBP and TFIIB binding. Our results demonstrate that large and small DNA viruses have a common interface with the host cell, namely the association with the RB tumour suppressor protein.

MeSH Terms
Adenovirus E1A Proteins/metabolism Cells, Cultured Cyclins/metabolism Cytomegalovirus/genetics Gene Expression Regulation Immediate-Early Proteins/metabolism Membrane Glycoproteins Phosphorylation Protein Binding Protein Kinases/metabolism Retinoblastoma Protein/metabolism Trans-Activators/metabolism Viral Envelope Proteins Viral Proteins
Chemicals
Adenovirus E1A Proteins Cyclins IE2 protein, Cytomegalovirus Immediate-Early Proteins Membrane Glycoproteins Retinoblastoma Protein Trans-Activators UL115 protein, Human herpesvirus 5 Viral Envelope Proteins Viral Proteins glycoprotein H, Cytomegalovirus glycoprotein H, Human cytomegalovirus glycoprotein O, cytomegalovirus Protein Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hagemeier C
Wellcome/CRC Institute, Cambridge, UK.
Caswell R
Hayhurst G
Sinclair J
Kouzarides T
References (45)
45 references, click to expand
  1. Cell DNA replication as a function in the synthesis of human cytomegalovirus.
    J Gen Virol. 1977 Oct;37(1):65-73 PMID: 199706
  2. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.
    Nature. 1991 Aug 8;352(6335):541-4 PMID: 1865909
  3. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.
    J Virol. 1990 Apr;64(4):1498-506 PMID: 2157038
  4. The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation.
    J Gen Virol. 1993 Dec;74 ( Pt 12):2691-8 PMID: 8277274
  5. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.
    Cell. 1992 Jul 24;70(2):337-50 PMID: 1638634
  6. Retinoblastoma protein and the cell cycle.
    Curr Opin Genet Dev. 1993 Feb;3(1):55-62 PMID: 8453276
  7. Transcriptional regulation by the retinoblastoma protein.
    Trends Cell Biol. 1993 Jul;3(7):211-3 PMID: 14731754
  8. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.
    Mol Cell Biol. 1992 Dec;12(12):5620-31 PMID: 1448092
  9. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection.
    Mol Cell Biol. 1992 Oct;12(10):4364-74 PMID: 1328853
  10. Tumor suppressor genes.
    Science. 1991 Nov 22;254(5035):1138-46 PMID: 1659741
  11. Identification of a human cytomegalovirus virus DNA segment that complements an adenovirus 5 immediate early mutant.
    Virology. 1986 Jun;151(2):329-38 PMID: 3010555
  12. Cell cycle regulation of the human cdc2 gene.
    EMBO J. 1992 May;11(5):1797-804 PMID: 1582409
  13. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
    Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1580-4 PMID: 8434021
  14. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.
    Cell. 1993 Feb 12;72(3):309-24 PMID: 8381715
  15. trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus.
    J Virol. 1988 Apr;62(4):1167-79 PMID: 2831379
  16. The retinoblastoma protein as a transcriptional repressor.
    Trends Cell Biol. 1993 Feb;3(2):43-6 PMID: 14731718
  17. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.
    Science. 1993 May 28;260(5112):1330-5 PMID: 8493578
  18. Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection.
    J Virol. 1982 Feb;41(2):462-77 PMID: 6281461
  19. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
    Cell. 1992 Jul 24;70(2):351-64 PMID: 1638635
  20. The E2F transcription factor is a cellular target for the RB protein.
    Cell. 1991 Jun 14;65(6):1053-61 PMID: 1828392
  21. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.
    Nature. 1988 Jul 14;334(6178):124-9 PMID: 2968522
  22. Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene.
    J Virol. 1989 Dec;63(12):5334-43 PMID: 2555558
  23. Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter.
    J Virol. 1990 Jul;64(7):3532-6 PMID: 2161955
  24. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
    Genes Dev. 1992 Feb;6(2):177-85 PMID: 1531329
  25. Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site.
    J Virol. 1991 Feb;65(2):887-96 PMID: 1846203
  26. Stimulation of cellular DNA synthesis by human cytomegalovirus.
    J Virol. 1974 Feb;13(2):353-62 PMID: 16789142
  27. Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains.
    J Virol. 1990 Apr;64(4):1556-65 PMID: 2157043
  28. A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2.
    J Virol. 1991 Feb;65(2):897-903 PMID: 1846204
  29. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.
    Nature. 1991 Jun 6;351(6326):494-7 PMID: 1710781
  30. Cellular targets for transformation by the adenovirus E1A proteins.
    Cell. 1989 Jan 13;56(1):67-75 PMID: 2521301
  31. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro.
    Nucleic Acids Res. 1993 Nov 11;21(22):4998-5004 PMID: 8255752
  32. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product.
    Mol Cell Biol. 1990 Jul;10(7):3761-9 PMID: 2162480
  33. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.
    J Virol. 1992 Jul;66(7):4452-6 PMID: 1318414
  34. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
    Cell. 1993 May 7;73(3):487-97 PMID: 8343202
  35. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Oncogene. 1991 Jul;6(7):1243-50 PMID: 1907361
  36. The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells.
    Nucleic Acids Res. 1991 Apr 25;19(8):1767-71 PMID: 1851560
  37. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
    Science. 1989 Feb 17;243(4893):934-7 PMID: 2537532
  38. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements.
    J Gen Virol. 1992 Sep;73 ( Pt 9):2385-93 PMID: 1328493
  39. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8489-93 PMID: 7690963
  40. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter.
    J Virol. 1993 Jan;67(1):323-31 PMID: 8380080
  41. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein.
    J Virol. 1992 Jul;66(7):4606-11 PMID: 1534854
  42. Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene.
    J Virol. 1988 Sep;62(9):3463-73 PMID: 2841497
  43. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.
    Cell. 1991 Jun 14;65(6):1073-82 PMID: 1828394
  44. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.
    Cell. 1988 Jul 15;54(2):275-83 PMID: 2839300
  45. Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.
    EMBO J. 1992 Jul;11(7):2603-10 PMID: 1385776
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1994-06-15
Pages
2897-903
Language
English
Region
England
NLM ID
8208664
PMCID
PMC395171
Subset
IM
Grants
Medical Research Council · G9202171 · United Kingdom
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com